Clinical trials of antiarrhythmic therapies and optimizing health care resource deployment: the need for a paradigm shift.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. Tailoring interventional arrhythmia therapy to individual patients: seeking the Art and the Science of Cardiac Electrophysiology in 2016.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2016
   Article
2. Antiarrhythmic therapy--the paradigm shifts in 2012: will it be enough to result in improved health care policies?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2013
   Article

Corrections and comments

• Comment on
  Twenty-five years of implantable defibrillator practice in the USA: are we ready for globalization?2011
• Comment on
  Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as